BFC Planning’s Greenwich LifeSciences GLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$35.2K Sell
1,950
-200
-9% -$3.33K ﹤0.01% 1735
2026
Q2
$50.4K Hold
2,150
– – ﹤0.01% 1545
2026
Q1
$51.6K Sell
2,150
-250
-10% -$6.52K ﹤0.01% 1324
2025
Q4
$50.4K Buy
2,400
+400
+20% +$4.21K ﹤0.01% 1367
2025
Q3
$19.9K Hold
2,000
– – ﹤0.01% 1583
2025
Q2
$18.1K Hold
2,000
– – ﹤0.01% 1537
2025
Q1
$19.1K Buy
2,000
+300
+18% +$3.64K ﹤0.01% 1481
2024
Q4
$19.1K Hold
1,700
– – ﹤0.01% 1478
2024
Q3
$24.4K Buy
+1,700
New +$25.2K ﹤0.01% 1368

Other funds holding GLSI

BFC Planning's GLSI Position: Q3 2026 in Review

BFC Planning reduced its Greenwich LifeSciences (GLSI) stake by 9.3% in Q3 2026, selling an estimated $3.33K and leaving 1,950 shares worth $35.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1735.

BFC Planning first reported a position in GLSI in Q3 2024 and has held it in 9 quarters since. The position peaked at $51.6K in Q1 2026. 41 funds tracked by Wall St. Rank hold GLSI as of Q3 2026.

  • BFC Planning held 1,950 shares of Greenwich LifeSciences worth $35.2K as of Q3 2026.
  • BFC Planning sold 200 Greenwich LifeSciences shares in Q3 2026, an estimated $3.33K.
  • Greenwich LifeSciences made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1735 holding.
  • BFC Planning first reported a position in Greenwich LifeSciences in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Greenwich LifeSciences position peaked at $51.6K in Q1 2026.
  • 41 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.